Simple blood test gets green light by FDA to improve early detection of Alzheimer’s disease

Simple blood test gets green light by FDA to improve early detection of Alzheimer’s disease - Millions of Americans are ...
BMJ

Neurological immune-related adverse events with checkpoint inhibitor therapy: challenges for the neurologist

Myositis-specific antibodies are positive in a third of patients, with a myopathic EMG and muscle oedema on MRI seen in the majority.2 After myositis, neuropathic N-irAEs are commonly reported.